Virus like particles as a platform for cancer vaccine development.

about

Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus.

P2860

Q55266915-C3181B77-15E9-4DF7-A7B5-55C5E48B6BCB

P2860

Virus like particles as a platform for cancer vaccine development.

Item

http://www.wikidata.org/entity/Q45324534

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Virus like particles as a platform for cancer vaccine development.

@en

Virus like particles as a platform for cancer vaccine development.

@nl

type

Item

label

Virus like particles as a platform for cancer vaccine development.

@en

Virus like particles as a platform for cancer vaccine development.

@nl

prefLabel

Virus like particles as a platform for cancer vaccine development.

@en

Virus like particles as a platform for cancer vaccine development.

@nl

P1476

Virus like particles as a platform for cancer vaccine development

@en

P2093

Hui Kian Ong

http://www.w3.org/2001/XMLSchema#string

Kok Lian Ho

http://www.w3.org/2001/XMLSchema#string

Wen Siang Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Critical appraisal of trastuzumab in treatment of advanced stomach cancer

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas

B lymphocytes secrete antigen-presenting vesicles

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems

P304

e4053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7717/PEERJ.4053

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wen Siang Tan

Kok Lian Ho

Hui Kian Ong

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29158984

http://www.w3.org/2001/XMLSchema#string

P932

5694210

http://www.w3.org/2001/XMLSchema#string

Virus like particles as a platform for cancer vaccine development.

about

P2860

P2860

Virus like particles as a platform for cancer vaccine development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932